Founder - Biohubb labs, Jaipur
Puneet Sethi is the Founder & CEO of Biohubb Labs, a biospecimen research and biobanking organization supporting global pharmaceutical, biotechnology, and clinical research institutions. With a background in pharmaceutical sciences and healthcare analytics, he founded Biohubb Labs to bridge the gap between clinical infrastructure and research needs. His work focuses on enabling ethical access to high-quality human biospecimens that accelerate drug development, biomarker discovery, and precision medicine.
SUMMARY
- Founded Biohubb Labs to enable ethical biospecimen sourcing and global research collaboration.
- Built a trusted network of hospitals and research partners supporting precision medicine and drug development.
- Focused on strengthening global research infrastructure through high-quality biospecimen access.
What inspired you to move from healthcare analytics into entrepreneurship and found Biohubb Labs?
During my work in healthcare analytics, I saw the gap between clinical data and actual biological samples needed for research. Many research organizations struggled to access quality biospecimens ethically and efficiently. This inspired me to build Biohubb Labs to create a reliable infrastructure that connects hospitals and researchers, enabling faster scientific discovery and advancing precision medicine.
Innovation in healthcare requires persistence, strong partnerships, and a long-term vision. Building Biohubb Labs taught me that trust and consistency are essential to creating meaningful impact in global research.
What was the core vision behind Biohubb Labs when you started it?
The core vision was to build a globally trusted biospecimen platform that enables researchers and pharmaceutical companies to access ethically sourced, high-quality human biospecimens. The goal was to accelerate drug discovery, biomarker research, and precision medicine by creating strong collaborations between hospitals, clinicians, and research organizations.
What has been the toughest challenge in building Biohubb Labs, and how did you overcome it?
The biggest challenge was building trust with hospitals and ensuring ethical, regulatory-compliant biospecimen sourcing. We overcame this by focusing on transparency, maintaining strict quality standards, and building long-term partnerships. Consistency, clear processes, and commitment to ethical practices helped establish Biohubb Labs as a trusted research partner.
In biospecimen research, how critical are trust and ethics, and how do you ensure them?
Trust and ethics are the foundation of biospecimen research. At Biohubb Labs, we ensure ethical sourcing through proper consent, regulatory compliance, and strict quality protocols. We work closely with hospitals and follow transparent processes to protect patient rights while enabling research that benefits global healthcare.
Our mission at Biohubb Labs is to empower global healthcare innovation by enabling seamless access to ethically sourced, high-quality biospecimens that accelerate research and precision medicine.
Which achievement of Biohubb Labs makes you most proud so far?
The achievement I am most proud of is building a trusted biospecimen network that supports global pharmaceutical, biotechnology, and research organizations. Knowing that Biohubb Labs contributes to research that can lead to new therapies, diagnostics, and medical advancements is extremely fulfilling.
How do you see India’s role in global healthcare research evolving in the next decade?
India has immense potential to become a global leader in healthcare research due to its strong clinical infrastructure, diverse patient population, and skilled medical professionals. With improved research infrastructure and ethical biobanking platforms like Biohubb Labs, India can significantly contribute to global drug discovery and precision medicine.
Where do you envision Biohubb Labs five years from now?
In the next five years, I envision Biohubb Labs becoming a globally recognized biospecimen research platform, collaborating with leading pharmaceutical and biotechnology companies worldwide. Our focus will be on expanding hospital partnerships, scaling biospecimen access, and strengthening research infrastructure to support global innovation.
What advice would you give to healthcare startups aiming to create meaningful impact?
Healthcare startups should focus on solving real problems that improve research or patient outcomes. Building trust, maintaining quality, and forming strong collaborations are critical. Success in healthcare requires patience, ethical commitment, and a long-term vision to create sustainable impact.
Focus on solving meaningful healthcare challenges, remain consistent, and build strong collaborative networks to create long-term impact in healthcare and research.
What does “innovation” truly mean to you in the context of healthcare?
Innovation in healthcare means creating solutions that improve research efficiency, enable better diagnostics, and accelerate treatment development. At Biohubb Labs, innovation involves building infrastructure that connects clinical resources with research needs, ultimately supporting scientific discovery and improving patient outcomes.
If you had one message for young professionals entering healthcare and research, what would it be?
Healthcare and research offer the opportunity to create real impact on global health. Stay curious, remain committed to ethical practices, and focus on contributing to meaningful solutions. With dedication and the right mindset, young professionals can play a key role in shaping the future of healthcare.
Trending Interviews
Trending Interviews
Related Popular Interviews
-
By Prerna Saini | March 11, 2026Divyansh Gupta: The Mind Behind Vipnik Studio’s 3D Animation
Read More
